NDC 71335-0496

Ondansetron

Ondansetron

Ondansetron is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Ondansetron.

Product ID71335-0496_1841d71d-8164-41f3-9d67-0ebf4d011d36
NDC71335-0496
Product TypeHuman Prescription Drug
Proprietary NameOndansetron
Generic NameOndansetron
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2010-04-12
Marketing CategoryANDA / ANDA
Application NumberANDA090469
Labeler NameBryant Ranch Prepack
Substance NameONDANSETRON
Active Ingredient Strength4 mg/1
Pharm ClassesSerotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-0496-0

30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0496-0)
Marketing Start Date2013-10-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0496-0 [71335049600]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-8 [71335049608]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-2 [71335049602]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-6 [71335049606]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-5 [71335049605]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-4 [71335049604]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-1 [71335049601]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-3 [71335049603]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-7 [71335049607]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

NDC 71335-0496-9 [71335049609]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA090469
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-15

Drug Details

Active Ingredients

IngredientStrength
ONDANSETRON4 mg/1

OpenFDA Data

SPL SET ID:53946863-72d0-4f28-bb1b-9d7421c9f8d5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 104894

    • Pharmacological Class

    • Serotonin 3 Receptor Antagonists [MoA]
    • Serotonin-3 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "Ondansetron" or generic name "Ondansetron"

    NDCBrand NameGeneric Name
    0143-2422OndansetronOndansetron hydrochloride
    0143-2423OndansetronOndansetron hydrochloride
    0143-2424OndansetronOndansetron
    0143-9890OndansetronOndansetron
    0143-9891OndansetronOndansetron
    0179-0099ondansetronondansetron hydrochloride
    0179-0100ondansetronondansetron hydrochloride
    0378-0315Ondansetronondansetron
    0378-0344Ondansetronondansetron
    0378-0374Ondansetronondansetron
    0378-7732OndansetronOndansetron
    0378-7734OndansetronOndansetron
    0404-9930ONDANSETRONONDANSETRON
    0409-1120OndansetronONDANSETRON
    0409-4755OndansetronONDANSETRON
    0409-4759OndansetronONDANSETRON
    0641-6078OndansetronOndansetron
    0641-6079OndansetronOndansetron
    0641-6080OndansetronOndansetron
    67877-169ondansetronondansetron
    67877-170ondansetronondansetron
    68001-247OndansetronOndansetron
    68001-246OndansetronOndansetron
    68071-1547OndansetronOndansetron
    68071-1804OndansetronOndansetron
    68071-1658OndansetronOndansetron
    68071-1730OndansetronOndansetron
    68071-1904OndansetronOndansetron
    68071-1649OndansetronOndansetron
    68071-1987OndansetronOndansetron
    68071-1968ONDANSETRONONDANSETRON
    68071-1977ONDANSETRONONDANSETRON
    68071-3028OndansetronOndansetron
    68071-3195OndansetronOndansetron
    68071-3268OndansetronOndansetron
    68071-4190OndansetronOndansetron
    68071-3275OndansetronOndansetron
    68071-4191ONDANSETRONONDANSETRON
    68071-4513OndansetronOndansetron
    68071-4426OndansetronOndansetron
    68071-4115OndansetronOndansetron
    68071-4566OndansetronOndansetron
    68071-4570OndansetronOndansetron
    68071-4409OndansetronOndansetron
    68071-4594OndansetronOndansetron
    68071-4810OndansetronOndansetron
    68071-4717OndansetronOndansetron
    68083-114OndansetronOndansetron
    68083-113OndansetronOndansetron
    68071-4529ondansetronondansetron
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.